Skip to content
OpenCapital
Get started

Clover Health Investments CLOV Investments Fair Value Disclosure

Other financials

Income statement

See full
Revenue$749.2M+62.0%
Operating income$27.3M+2,246%
Net income$27.3M+2,246%
EPS (diluted)$0.05—

Balance sheet

See full
Cash & equivalents$173.3M+11.5%
Total debt$3.3M-0.9%
Total equity$339.4M+1.0%
Total assets$697.7M+19.5%

Cash flow

See full
Operating cash flow$107.9M+762%
CapEx$854.0K+362%
Free cash flow$107.0M+750%

Valuation

See full
Market cap$2.67B-49.7%
P/S1.2×-2.4×

Profitability

See full
Operating margin-2.6%+3.5pp
Net margin-2.6%+2.8pp
FCF margin-10.3%—

Returns & leverage

See full
Return on equity-16.9%-170pp
Debt / equity0×0.0×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by Clover Health Investments in its filing.

Tagged under the XBRL concept us-gaap:InvestmentsFairValueDisclosure.

The official record: Clover Health Investments’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clover Health Investments's investments fair value disclosure.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clover Health Investments's investments fair value disclosure?
Clover Health Investments (CLOV) reported investments fair value disclosure of $240.52M in Q1 2026.
How has Clover Health Investments's investments fair value disclosure changed year-over-year?
Clover Health Investments's investments fair value disclosure increased by 2.3% year-over-year, from $235.17M to $240.52M.
What is the long-term trend for Clover Health Investments's investments fair value disclosure?
Over 5 years (2020 to 2025), Clover Health Investments's investments fair value disclosure has grown at a 32.6% compound annual growth rate (CAGR), from $54.7M to $224.5M.